This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results. (September 2019)
Record Type:
Journal Article
Title:
First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results. (September 2019)
Main Title:
First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results